Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-13 Purchase | 2024-05-15 07:04 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 30,000 | $5.47 | $164,100 | 307,533 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 4:48 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 6,100 | $10.9 | $66,490 | 211,610 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-14 Tax Withholding | 2024-12-17 4:22 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 8,251 | $7.53 | 300,057 (Direct) | View |
| 2023-12-19 Tax Withholding | 2023-12-20 4:38 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 2,482 | $6.05 | 274,533 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 4:40 pm | 2024-12-14 2033-12-14 | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 192,500 | $0 | 435,515 (Direct) | View |
| 2023-12-14 Tax Withholding | 2023-12-18 4:40 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 5,840 | $6.43 | 435,515 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 4:34 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 192,500 | $0 | 404,110 (Direct) | View |
| 2021-12-14 Option Award(A) | 2022-01-13 4:38 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 80,000 | $0 | 216,556 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 5:12 pm | 2022-12-14 2031-12-14 | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 289,000 | $0 | 425,556 (Direct) | View |
| 2020-12-15 Option Award | 2020-12-17 4:37 pm | 2021-12-15 2030-12-15 | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Vice President and CCO | 190,000 | $0 | 190,000 (Direct) | View |
Ownership | 2020-01-21 08:59 am | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Vice President and CCO | 0 | $0 | 471,794 (Direct) | View |